In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae

Vaborbactam (formerly RPX7009) is a novel inhibitor of serine β-lactamases, including Ambler class A carbapenemases, such as KPCs. The current study evaluated the in vitro activity of the combination agent meropenem-vaborbactam against a global collection of 991 isolates of KPC-positive Enterobacter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hackel, Meredith A., Lomovskaya, Olga, Dudley, Michael N., Karlowsky, James A., Sahm, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740317/
https://www.ncbi.nlm.nih.gov/pubmed/29084745
http://dx.doi.org/10.1128/AAC.01904-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740317/
https://www.ncbi.nlm.nih.gov/pubmed/29084745
http://dx.doi.org/10.1128/AAC.01904-17

Ejemplares similares